title: Nanofiber scaffolds for treatment of spinal cord injury.
abstract: Spinal cord injury (SCI) is a common neurologic disorder that results in loss of sensory function and mobility. It is well documented that tissue engineering is a potential therapeutic strategy for treatment of SCI. In this connection, various biomaterials have been explored to meet the needs of SCI tissue engineering and these include natural materials, synthetic biodegradable polymers and synthetic non- degradable polymers. Nanofiber scaffolds are newly emerging biomaterials that have been widely utilized in tissue engineering recently. In comparison to the traditional biomaterials, nanofibers have advantages in topography and porosity, thus mimicking the naturally occurring extracellular matrix. Besides, they exhibit excellent biocompatibility with low immunogenicity, and furthermore they are endowed with properties that help to bridge the lesion cavity or gap, and serve as an effective delivery system for graft cells or therapeutic drugs. This review summarizes some of the unique properties of nanofiber scaffolds which are critical to their potential application in treatment of injured spinal cord.
authors.forename: Jia-Song
authors.initials: JS
authors.lastname: Guo
authors.forename: Chang-Hui
authors.initials: CH
authors.lastname: Qian
authors.forename: Eng-Ang
authors.initials: EA
authors.lastname: Ling
authors.affiliation: Department of Histology and Embryology, Southern Medical University, Guangzhou 510515, China. jiasongguo@aliyun.com.
authors.forename: Yuan-Shan
authors.initials: YS
authors.lastname: Zeng
mesh_terms: D016503:Drug Delivery Systems; D006801:Humans; D057139:Nanofibers / Q000627:therapeutic use*; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism*